Skip to content
TrustList
venBio logo
Investor

venBio

Life sciences investment firm building new medicines and technologies for unmet medical needs

  • Manufacturing
  • Medical
  • Series C
  • Partners
  • +5 more
venBio cover

About venBio

Life sciences investing is the work of venBio, a firm that partners with industry leaders to build new medicines and technologies. It concentrates on new therapies where medical need is not yet being met, and it says it looks for teams developing treatments that could have a meaningful effect on patient care. The firm runs several venture funds, and its portfolio activity covers cell therapy, oncology, radiopharmaceuticals and eye disease.

Planning for the buyer from the start

The firm says it considers potential acquisition partners from the outset and sets each company up to meet what those partners will need. That work covers intellectual property, chemistry and manufacturing, and the design of clinical trials, including the indication being treated, the trial design, the endpoints, the statistical power of the study and the regulatory questions that follow.

Development planning and hands-on involvement

Its team helps companies choose a development plan that can carry a therapy through to patients. The firm describes this involvement as a way of helping each company make a larger impact, and it says the relationships it builds with the leaders it works alongside are lasting ones.

TrustList summary

VenBio is a life sciences investment firm that works with industry leaders to develop new medicines and technologies. Its emphasis is on novel therapeutics for conditions with unmet medical needs. The firm has run several venture funds.

What venBio offers

  • Therapeutics investment: backs companies developing treatments with meaningful patient impact.
  • Development planning: helps teams shape a route to bringing therapies to patients.
  • Exit readiness: considers potential acquirers from the start, covering intellectual property, manufacturing and clinical trial design.
  • Hands-on involvement: draws on its team's expertise to help companies make a bigger impact.

Who it works with

The firm partners with biotech teams and industry leaders. Its news lists portfolio activity in cell therapy, oncology and radiopharmaceuticals, eye disease and other clinical programmes, including public offerings by several portfolio companies.

Key facts

  • Focus: life sciences and novel therapeutics
  • Portfolio areas: cell therapy, oncology, radiopharmaceuticals and ophthalmology

Summary written by TrustList from the business's own published information, Nov 2026.

Categories & features

Ask TrustList to introduce you to venBio

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of venBio

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about venBio.

venBio alternatives

Similar listings buyers compare against this one.

Venture capital firm investing in early-stage life sciences companies, mainly in Europe and Israel

A local venture capital investor co-financing young technology companies alongside private investors

Venture fund dedicated to pet care and animal health startups, run by Digitalis Ventures

Renewable energy investment manager within Schroders Capital, active across the UK, Europe and North America

Early-stage technology investor partnering with founders building software and internet companies in Africa and other under-followed markets

Boston venture fund making early-stage investments in founders chosen for emotional intelligence

Early-stage venture firm backing technical founders from pre-seed to Series A across hardware-led sectors